Clinical Trial Update: Pyridostigmine in Severe SARS-CoV-2 Infection [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for pyridostigmine in severe SARS-CoV-2 infection proceeding through Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2

Drugs mentioned

• Pyridostigmine (pyridostigmine)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: COVID-19, SARS-CoV-2 | Phase 2, Phase 3 | Status: UNKNOWN